Search alternatives:
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
8141
PCAIs suppress NCI-H23 cancer cell migration.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
8142
PCAIs induce apoptosis in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
8143
-
8144
DNMT1 reduces cisplatin sensitivity partially through downregulating FOXO3a in ovarian cancer cells
Published 2025“…Knocking down of DNMT1 could decrease the IC<sub>50</sub> of cisplatin. Treatment with cisplatin may reduce FOXO3a expression in OC cells. …”
-
8145
-
8146
-
8147
Suppression by extracellular QRNA from TNP Ts Sup free of exosomes, or miR-150 alone, associating with B-cell derived Ag-specific exosomes from the assayed CS-effector cell mixture...
Published 2015“…</b></u> Similarly, two day immune B-1 B cell-derived exosomes, supplemented with decreasing doses of miR-150 alone, mediated suppression of TNP-CS-effector cell adoptive transfer (Groups E-G), down to a dose of 750pg per eventual recipient, which is 50 femtomoles per eventual recipient (Group G). …”
-
8148
Drebrin regulates RMS neuroblast migration <i>in vitro</i>.
Published 2015“…The GFP channel is shown as a grayscale image. (B) Drebrin-depleted neuroblasts (black column) show a ~20% decrease in migration distance compared to control shRNA-nucleofected cells (white column). …”
-
8149
-
8150
-
8151
-
8152
The proliferation and angiogenesis of the fat pad.
Published 2015“…<p>A: The number of Ki67+ cells (white arrow) was increased during expension (day 0 left, day 14 right). …”
-
8153
-
8154
DataSheet1_Assessing susceptibility for polycyclic aromatic hydrocarbon toxicity in an in vitro 3D respiratory model for asthma.PDF
Published 2024“…Cells with the IL-13 phenotype treated with BAP result in significantly (p < 0.05) decreased barrier integrity, less than 50% compared to normal cells. …”
-
8155
Data_Sheet_1_The Virulence of Escherichia coli O157:H7 Isolates in Mice Depends on Shiga Toxin Type 2a (Stx2a)-Induction and High Levels of Stx2a in Stool.docx
Published 2020“…<p>In this study we compared nine Shiga toxin (Stx)-producing Escherichia coli O157:H7 patient isolates for Stx levels, stx-phage insertion site(s), and pathogenicity in a streptomycin (Str)-treated mouse model. …”
-
8156
-
8157
-
8158
Drebrin phosphorylation on S142 regulates neuroblast morphology and orientation <i>in vivo</i>.
Published 2015“…(B) Quantitative morphological analysis also shows a decrease in leading process length for wt, S142A and S142D compared to the control (mean ± SEM; n = 8 brains for empty vector; n = 5 brains for wt, S142A, and S142D drebrin; *<i>P</i><0.05, **<i>P</i><0.01, ***<i>P</i><0.001). …”
-
8159
-
8160